Cargando…
Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma
BACKGROUND: Patients with advanced thyroid carcinoma (TC), such as anaplastic thyroid carcinoma (ATC), poorly differentiated thyroid carcinoma (PDTC), and locally advanced papillary thyroid carcinoma (PTC), have poor prognoses and require novel treatments. Immune checkpoint (ICP) inhibitors have dem...
Autores principales: | Luo, Yi, Yang, Yi-Chen, Shen, Cen-Kai, Ma, Ben, Xu, Wei-Bo, Wang, Qi-Feng, Zhang, Yan, Liao, Tian, Wei, Wen-Jun, Wang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094437/ https://www.ncbi.nlm.nih.gov/pubmed/35574031 http://dx.doi.org/10.3389/fendo.2022.859013 |
Ejemplares similares
-
Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021) -
Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma
por: Banerjee, Sohini, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management
por: Zhan, Ling, et al.
Publicado: (2021) -
The Association Between Lymph Node Stage and Clinical Prognosis in Thyroid Cancer
por: Zhang, Junyi, et al.
Publicado: (2020)